When did Guardant Health report Q4 2024 earnings?

Guardant Health (GH) reported Q4 2024 earnings on February 20, 2025 after market close.

What were Guardant Health's Q4 2024 revenue and EPS?

Guardant Health reported revenue of $201.8M and diluted EPS of $-0.62 for Q4 2024.

Did Guardant Health beat estimates in Q4 2024?

Revenue beat the consensus estimate of $192.5M by $9.3M. EPS beat the consensus estimate of $-0.75 by $0.13.

Where can I find Guardant Health's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001576280-25-000044) directly on SEC EDGAR. The filing index links above go to sec.gov.

Guardant Health GH Q4 2024 Annual earnings

Reported February 20, 2025 · After market close

Revenue$201.8MBeat by $9.3M Diluted EPS-$0.62Beat by $0.13

Revenue estimate$192.5M

EPS estimate-$0.75

Next report

Jul 29, 2026 (In 2 weeks)

Revenue estimate$314.2M

EPS estimate-$0.41

Financials

Q4 2024

Income statement

See full

Revenue$201.8M+30.2%

Gross profit$124.2M+47.5%

Operating income-$126.0M+36.2%

Net income-$111.0M+40.7%

EPS (diluted)-$0.90+44.4%

Balance sheet

See full

Cash & equivalents$629.8M-44.5%

Total debt$1.3B+525%

Total equity-$139.6M-188%

Total assets$1.5B-16.8%

Cash flow

See full

Operating cash flow-$64.5M+18.1%

CapEx$18.9M+363%

Free cash flow-$83.4M-0.7%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$3.77B+15.0%

Enterprise value$4.48B+89.6%

P/S5.1×-0.7×

Profitability

See full

Gross margin60.8%+1.0pp

Operating margin-60%-17.2pp

Net margin-59%-13.8pp

FCF margin-37.2%-10.5pp

Returns & leverage

See full

Current ratio4.7×-1.9×

Segments

By product

See full

Oncology$145.6M+44.2%

Biopharma and data$49.5M+45.2%

Screening$4.1M—

Licensing and other$2.6M-56.7%

By segment

See full

Reportable Segment$201.8M+43.1%

By geography

See full

United States$191.6M+34.3%

Versus estimates

Revenue

Q1 2026$301.7MBeat by $22.5M Q4 2025$281.3MBeat by $8.8M Q3 2025$265.2MMiss by $2.4M Q2 2025$232.1MMiss by $3.6M Q1 2025$203.5MMiss by $8.0M

Q4 2024$201.8MBeat by $9.3M

Diluted EPS

Q1 2026-$0.85Miss by $0.38 Q4 2025-$0.90Miss by $0.13 Q3 2025-$0.39Beat by $0.09 Q2 2025-$0.44Beat by $0.08 Q1 2025-$0.49Beat by $0.12

Q4 2024-$0.62Beat by $0.13

Ask the moment Guardant Health reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Guardant Health report Q4 2024 earnings?: Guardant Health (GH) reported Q4 2024 earnings on February 20, 2025 after market close.
What were Guardant Health's Q4 2024 revenue and EPS?: Guardant Health reported revenue of $201.8M and diluted EPS of $-0.62 for Q4 2024.
Did Guardant Health beat estimates in Q4 2024?: Revenue beat the consensus estimate of $192.5M by $9.3M. EPS beat the consensus estimate of $-0.75 by $0.13.
Where can I find Guardant Health's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001576280-25-000044) directly on SEC EDGAR. The filing index links above go to sec.gov.